TGFB1 and hepatocellular carcinoma: Analysis of the Cancer Genome Atlas (TGCA) dataset of HCC samples revealed that clusters with highly activated TGF-β signatures had more pronounced immune exhaustion and poorer prognosis, suggesting that ICI therapy may be less effective [27,28].